ArticleJournal of neuro-oncology2026
Visual outcomes of sight threatening radiation-induced meningiomas after low-dose head irradiation: tinea capitis as a paradigm.
Article in Journal of neuro-oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo investigate the visual characteristics and prognosis of vision-threatening meningiomas following low dose head radiation and compare them to those of primary unexposed meningiomas.
methodsA retrospective cohort of adults with meningiomas adjacent to the optic nerves or intracranial visual pathways was categorized into radiation-exposed and unexposed meningiomas. Data collected included demographics, visual biomarkers at presentation and at final follow-up, including Visual Acuity (VA), color vision (CV), Visual Field (VF) and peripapillary Retinal Nerve Fiber Layer (RNFL) thickness via Optical coherence tomography (OCT). Comparative analyses were performed between radiation-exposed and unexposed cohorts.
results289 eligible patients seen between 2004 and 2023 were included, out of which 31 (10.7%) had undergone tinea capitis radiation. At presentation, patients exhibited a median BCVA of 0.1 LogMAR [IQR 0.1-0.6], median CV of 100% [IQR 64.5%-100%], and 9 (29%) had normal visual fields. Notably, 16 (51.61%) experienced visual loss. Their BCVA decreased at final follow-up, to median 0.23 [IQR 0.1-1.46]. Comparative analysis with 114 radiation-naïve patients with meningioma-induced visual loss revealed no statistically significant disparities in visual characteristics at presentation or at follow-up.
conclusionsNo statistically significant differences in clinical presentation or visual prognosis were detected between patients with visual pathway meningiomas exposed to low-dose childhood radiation and radiation-naïve patients. Since low-dose cranial irradiation continues to be widely used for conditions such as thyroid eye disease, our findings are relevant beyond the specific context of tinea capitis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.